ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RCP Rit Capital Partners Plc

1,820.00
34.00 (1.90%)
Last Updated: 10:17:18
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rit Capital Partners Plc LSE:RCP London Ordinary Share GB0007366395 ORD �1
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  34.00 1.90% 1,820.00 1,816.00 1,822.00 1,820.00 1,790.00 1,790.00 55,354 10:17:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt 108.8M 66.1M 0.4508 40.02 2.65B

RIT Capital Partners PLC Directorate Change (2611M)

26/04/2018 12:41pm

UK Regulatory


Rit Capital Partners (LSE:RCP)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Rit Capital Partners Charts.

TIDMRCP

RNS Number : 2611M

RIT Capital Partners PLC

26 April 2018

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

26 April 2018

Election of Directors

Following the passing of all resolutions by shareholders at its Annual General Meeting, RIT Capital Partners plc ('RIT') announces the following elections to the Board with immediate effect:

André Perold

André Perold has been elected to the Board as a Non-Executive Director. Mr Perold is a Co-Founder, Managing Partner and Chief Investment Officer of HighVista Strategies, a Boston based investment firm. He is a board member of the Vanguard Group, the global investment company and also serves on the Investment Committee of the Partners Healthcare System.

Mr Perold will sit on the Audit & Risk Committee.

There are no other details that require to be disclosed in respect of the appointment of Mr Perold pursuant to Rule 9.6.13 of the UK Listing Rules.

Jeremy Sillem

Jeremy Sillem has been elected to the Board as a Non-Executive Director. Mr Sillem is Managing Partner and Founder of Spencer House Partners LLP, which provides corporate finance advice to asset and wealth management businesses. From 2000 to 2004 he was Executive Chairman of Bear Stearns International in London, prior to which he had a 28-year career with Lazard in London and New York.

Mr Sillem will sit on the Audit & Risk Committee.

Mr Sillem is currently a director of Biopharma Credit PLC. There are no other details that require to be disclosed in respect of the appointment of Mr Sillem pursuant to Rule 9.6.13 of the UK Listing Rules.

Composition of Board Committee

Phillipe Costeletos has been appointed as a member of the Remuneration Committee of RIT, with immediate effect.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAFQLFLVZFZBBB

(END) Dow Jones Newswires

April 26, 2018 07:41 ET (11:41 GMT)

1 Year Rit Capital Partners Chart

1 Year Rit Capital Partners Chart

1 Month Rit Capital Partners Chart

1 Month Rit Capital Partners Chart

Your Recent History

Delayed Upgrade Clock